Scisparc Ltd Receivables Turnover Ratio (SPRC), from the fourth quarter 2025 to the fourth quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Scisparc Ltd  (NASDAQ: SPRC)
 

Scisparc Ltd Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Scisparc Ltd's ability to collect accounts receivable sequentially worsen to 77.82, indicating more challenging environment then in the third quarter 2025, but still, it is a far cry from any concerns. Scisparc Ltd's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 5 days, from 1 days, in the 0 quarter.

If we take a look into Healthcare sector 515 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from to 3569.

What is Receivable Turnover Ratio?
What is Scisparc Ltd Selling?


What is Receivable Turnover Ratio?





SPRC Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Receivable Change 0 % -47.37 % -36.36 % -54.55 % -76.74 %
Y / Y Revenue Change -70.27 % - - - 113.73 %
Receivable Turnover Ratio (TTM) 77.82 261.73 217.28 188.79 157.75
SPRC's Total Ranking # 3569 # # # #
Accounts Receivable average collection period days 5 1 2 2 2
Seq. Receivable Change 0 % -28.57 % 40 % 0 % -47.37 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 176
Healthcare Sector # 516
Overall Market # 3569

Receivable Turnover Ratio Statistics
High Average Low
0.27 0.17 0.12
(Dec 31 2023)   (Dec 31 2022)






Financial Statements
Scisparc Ltd's Accounts Receivable $ 0 Millions Visit SPRC's Balance sheet
Scisparc Ltd's Sales TTM $ 1 Millions Visit SPRC's Income Statement
Sources of SPRC's Revenues Visit SPRC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SPRC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SPRC's Growth Rates SPRC's Roa SPRC's Inventory Turnover Ratio SPRC's Dividend Comparisons
SPRC's Profitability Ratios SPRC's Roi SPRC's Asset Turnover Ratio SPRC's Dividend Growth
SPRC's Valuation Ratios SPRC's Roe SPRC's Financial Strength Ratios SPRC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Ginkgo Bioworks Holdings Inc   226.19 $ 170.155  Millions$ 0.752  Millions
Fortress Biotech Inc   216.84 $ 63.262  Millions$ 0.292  Millions
Zeo Scientifix Inc   200.18 $ 5.555  Millions$ 0.028  Millions
Arcus Biosciences Inc   197.60 $ 247.000  Millions$ 1.250  Millions
Immunocore Holdings Plc  181.15 $ 400.016  Millions$ 2.208  Millions
Arrowhead Pharmaceuticals Inc   169.72 $ 1,090.981  Millions$ 6.428  Millions
Earth Science Tech Inc   159.09 $ 32.891  Millions$ 0.207  Millions
Assembly Biosciences Inc   153.35 $ 72.303  Millions$ 0.472  Millions
Koninklijke Philips Nv  149.87 $ 19,974.080  Millions$ 133.280  Millions
Prime Medicine Inc   135.24 $ 4.632  Millions$ 0.034  Millions
Genmab A  130.53 $ 3,720.000  Millions$ 28.500  Millions
Bridgebio Oncology Therapeutics Inc   117.58 $ 11.347  Millions$ 0.097  Millions
Logicmark Inc  114.88 $ 11.426  Millions$ 0.099  Millions
Harvard Apparatus Regenerative Technology Inc   100.57 $ 0.704  Millions$ 0.007  Millions
Mangoceuticals Inc   90.95 $ 0.456  Millions$ 0.005  Millions
Immutep Limited  88.58 $ 10.331  Millions$ 0.117  Millions
Sbc Medical Group Holdings Incorporated  76.66 $ 171.922  Millions$ 2.243  Millions
Aclaris Therapeutics Inc   70.50 $ 7.826  Millions$ 0.111  Millions
Agape Atp Corporation  70.27 $ 1.524  Millions$ 0.022  Millions
Humacyte Inc   67.98 $ 40.803  Millions$ 0.600  Millions
Takeda Pharmaceutical Company Limited  65.19 $ 29,183.898  Millions$ 447.687  Millions
Airsculpt Technologies Inc   59.97 $ 151.818  Millions$ 2.532  Millions
Spero Therapeutics Inc   56.29 $ 66.802  Millions$ 1.187  Millions
Crinetics Pharmaceuticals Inc   52.00 $ 7.696  Millions$ 0.148  Millions
Brookdale Senior Living Inc   51.27 $ 3,194.066  Millions$ 62.298  Millions
Eyepoint Inc   45.42 $ 31.371  Millions$ 0.691  Millions
X4 Pharmaceuticals Inc  45.05 $ 35.113  Millions$ 0.780  Millions
Fortrea Holdings Inc   44.55 $ 2,723.400  Millions$ 61.125  Millions
Longduoduo Co Ltd  44.55 $ 2.722  Millions$ 0.061  Millions
Lifevantage Corp  44.29 $ 208.401  Millions$ 4.705  Millions

Date modified: 2026-07-07T13:49:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.